Mapping multimorbidity from diabetes mellitus and its association with depressive symptoms among older people of India: a cross-sectional study from a nationally representative survey
{"title":"Mapping multimorbidity from diabetes mellitus and its association with depressive symptoms among older people of India: a cross-sectional study from a nationally representative survey","authors":"Gayatri Khanal, Y. Selvamani, J. Kezia Angeline","doi":"10.1007/s13410-024-01327-3","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>India is the second major epicenter of diabetes mellitus (DM) prevalence after China and predicted to overtake China by 2045. DM is associated with multimorbidity which has tremendous impact on mental health. However, little is known about patterns of morbidities and their associations with depression. </p><h3 data-test=\"abstract-sub-heading\">Objective</h3><p>The purpose of this article is to ascertain multimorbidity in the DM population and to assess the relationship between multimorbidity and depressive symptoms.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>A cross-sectional analysis was conducted using data from the “Longitudinal Ageing Study in India (LASI),” a national representative survey. Regression analysis was used to investigate the relationship between multimorbidity and depressive symptoms. The mean difference of depressive symptoms with multimorbidity was calculated using one-way ANOVA.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>The total population included in the study was 8855. Around 72.8% had multimorbidity, out of which 43%, 20.4%, and 9.4% fall under single, double, and triple or more than triple morbidity category, respectively. The odds of having depression in single morbidity (AOR, 1.24), double morbidity (AOR, 1.34), and triple or more morbidity (AOR, 1.51), poor self-rated health (AOR, 1.45), unenrolled in health insurance policy (AOR, 1.21), hospitalized in the past 12 months (AOR, 1.12), and taking insulin injections (AOR, 1.24) were significantly higher. There were significant mean differences in depression with different categories of multimorbidity conditions (<i>F</i> = 19.63, <i>p</i> = 0.000).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Higher rate of multimorbidity among DM patients was recorded. Multimorbidity substantially increases the risk of acquiring depression. Timely identification and appropriate management multimorbidity of diabetes are important for reducing to incidence of depression and better quality of life and functionality.</p>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Diabetes in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13410-024-01327-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background
India is the second major epicenter of diabetes mellitus (DM) prevalence after China and predicted to overtake China by 2045. DM is associated with multimorbidity which has tremendous impact on mental health. However, little is known about patterns of morbidities and their associations with depression.
Objective
The purpose of this article is to ascertain multimorbidity in the DM population and to assess the relationship between multimorbidity and depressive symptoms.
Methods
A cross-sectional analysis was conducted using data from the “Longitudinal Ageing Study in India (LASI),” a national representative survey. Regression analysis was used to investigate the relationship between multimorbidity and depressive symptoms. The mean difference of depressive symptoms with multimorbidity was calculated using one-way ANOVA.
Results
The total population included in the study was 8855. Around 72.8% had multimorbidity, out of which 43%, 20.4%, and 9.4% fall under single, double, and triple or more than triple morbidity category, respectively. The odds of having depression in single morbidity (AOR, 1.24), double morbidity (AOR, 1.34), and triple or more morbidity (AOR, 1.51), poor self-rated health (AOR, 1.45), unenrolled in health insurance policy (AOR, 1.21), hospitalized in the past 12 months (AOR, 1.12), and taking insulin injections (AOR, 1.24) were significantly higher. There were significant mean differences in depression with different categories of multimorbidity conditions (F = 19.63, p = 0.000).
Conclusion
Higher rate of multimorbidity among DM patients was recorded. Multimorbidity substantially increases the risk of acquiring depression. Timely identification and appropriate management multimorbidity of diabetes are important for reducing to incidence of depression and better quality of life and functionality.
期刊介绍：
International Journal of Diabetes in Developing Countries is the official journal of Research Society for the Study of Diabetes in India. This is a peer reviewed journal and targets a readership consisting of clinicians, research workers, paramedical personnel, nutritionists and health care personnel working in the field of diabetes. Original research articles focusing on clinical and patient care issues including newer therapies and technologies as well as basic science issues in this field are considered for publication in the journal. Systematic reviews of interest to the above group of readers are also accepted.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
